Vancomycin is the most common antibiotic for treatment of MRSA, according to a news release. It is the first time a vancomycin-resistant strain of MRSA has been known to cause a bloodstream infection.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The strain’s vancomycin resistance originated in the community, rather than the hospital, according to the study. This is potentially problematic because community-associated MRSA is associated with easily transmittable skin infections in people of all ages and health statuses, according to a news release.
More Articles on Infection Control & Clinical Quality:
Level of Drug Resistance Does Not Predict HAI Mortality, Study Finds
12 Million U.S. Adults Misdiagnosed Every Year
Patient Safety Tool: Assessment of Appropriateness of Antibiotics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
